Expression of MiR- 183 and let- 7 Family in Serum of Patients with Hepatocellular Carcinoma
YANG Guang,WANG Zhan-bao,DONG Xin,YU Ming-gang
Tianjin Third Center Hospital Branch, Tianjin (300250), China
Abstract:
Objective To detect the expression and signi?cance of serum miR-182, miR-96, let-7a, let-b, let-7c and let-7e in hepatocellular carcinoma. Methods Fifty-eight hepatocellular cancer serum samples, 30 liver cirrhosis serum samples, 40 hepatitis serum samples and 40 healthy control serum samples were collected for detection of miR-182, miR-96, let-7a, let-b, let-7c and let-7e by real-time quantitative PCR; then the relative expression of target miRNA in four groups were analyzed and the relation between miRNA and clinicopathologic feature were also explored. Results Expression of serum miR-182 and miR-96 in hepatocellular carcinoma was higher than that in liver cirrhosis, hepatitis and healthy controls (P < 0. 01). The expression of serum miR- 96 in hepatitis was higher than that in healthy controls (P<0.01); Serum let-7c in hepatocellular carcinoma was higher than that in hepatitis (P<0.01). Expression of serum let-7e in hepatocellular carcinoma was higher than that in liver cirrhosis (P <0.05). Conclusion Serum miR- 182 and miR- 96 may have diagnostic value for hepatocellular carcinoma and can predict the malignant degree and prognosis; Serum let-7 family may have poor diagnostic value for hepatocellular carcinoma.